http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014318741-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
filingDate 2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_479f4be7b87f3931f1801c9011fc51e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3925ae8f05617f9d6e8c7930c13a0af6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dea3a62748ed992b5d5e24c55634543c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61297ab5cb1b04c46683610bbf185571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31a34351b62b854cddea76024af36f5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_354b722c984068e77674441b161dc6a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e86df25ea187a14ac2d5cf5152206107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_201140e4824ff2ba1578b8accaa11725
publicationDate 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2014318741-A1
titleOfInvention Formulations for CGRP receptor antagonists
abstract The instant invention relates to liquid pharmaceutical compositions containing CGRP receptor antagonists. The CGRP receptor antagonist liquid pharmaceutical compositions of the instant invention are alcohol-free, low volume liquid pharmaceutical compositions that can be taken without water for the treatment of migraine headache.
priorityDate 2013-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415722021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426254013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90011666
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51064083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68748835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423352616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426176038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9810996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425321872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11319053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9222
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420238839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413592464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431332077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526627

Total number of triples: 69.